Drug profile · INN
saxagliptin + metformin
KOMBIGLYZE XR 2.5/1000
saxagliptin + metformin (KOMBIGLYZE XR 2.5/1000) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — saxagliptin + metformin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
saxagliptin + metformin (KOMBIGLYZE XR 2.5/1000) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is saxagliptin + metformin?
saxagliptin + metformin (KOMBIGLYZE XR 2.5/1000) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for saxagliptin + metformin?
KOMBIGLYZE XR 2.5/1000 is a marketed brand name for saxagliptin + metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.